Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

RHODES PHARMS

  • FDA Approval
  • March 21, 2024, 08:55 UTC
  • 42
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Comment Full text

DR REDDYS LABS SA

  • FDA Approval
  • March 21, 2024, 08:55 UTC
  • 42
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Comment Full text

CADILA

  • FDA Approval
  • March 21, 2024, 08:55 UTC
  • 45
  • 0 comments

FDA approve HYDROCHLOROTHIAZIDE; TRIAMTERENE

Comment Full text

DR REDDYS LABS SA

  • FDA Approval
  • March 21, 2024, 08:55 UTC
  • 41
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Comment Full text

ANNORA PHARMA

  • FDA Approval
  • March 21, 2024, 08:55 UTC
  • 47
  • 0 comments

FDA approve VENLAFAXINE HYDROCHLORIDE

Comment Full text

AUROLIFE PHARMA LLC

  • FDA Approval
  • March 20, 2024, 08:55 UTC
  • 43
  • 0 comments

FDA approve METHADONE HYDROCHLORIDE

Comment Full text

NOVEL LABS INC

  • FDA Approval
  • March 20, 2024, 08:55 UTC
  • 37
  • 0 comments

FDA approve ACETAMINOPHEN; HYDROCODONE BITARTRATE

Comment Full text

ALEMBIC

  • FDA Approval
  • March 20, 2024, 08:55 UTC
  • 42
  • 0 comments

FDA approve MESALAMINE

Comment Full text

L PERRIGO CO

  • FDA Approval
  • March 20, 2024, 08:55 UTC
  • 47
  • 0 comments

FDA approve NICOTINE POLACRILEX

Comment Full text

TORRENT

  • FDA Approval
  • March 20, 2024, 08:55 UTC
  • 38
  • 0 comments

FDA approve FAMOTIDINE; IBUPROFEN

Comment Full text
  • Previous
  • 523
  • 524
  • 525
  • 526
  • 527
  • Next

Search

News categories

  • Technical Exchange News(14694)
  • Event(6229)
  • SEC News(393628)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(239534)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin